Cite
HARVARD Citation
Mazurov, V. et al. (n.d.). OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study. Annals of the rheumatic diseases. p. 64. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mazurov, V. et al. (n.d.). OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study. Annals of the rheumatic diseases. p. 64. [Online].